What is Vera Therapeutics Inc (VERA) stock price today?

Vera Therapeutics Inc (VERA) currently trades at $35.84 per share. The stock has a market capitalization of $2.57B and a P/E ratio of —x.

Is VERA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Vera Therapeutics Inc has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is 3.10.

Is Vera Therapeutics Inc financially healthy?

Vera Therapeutics Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of 3.10 places it in the safe zone.

VERA

Vera Therapeutics Inc

NASDAQ: VERA · HEALTHCARE · BIOTECHNOLOGY

$35.84

-3.42% today

Updated 2026-04-29

Market cap

$2.57B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.66

Dividend yield

—

52W range

$19 – $56

Volume

1.2M

Market cap

$2.57B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.66

Dividend yield

—

52W range

$19 – $56

Volume

1.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

3.1

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$79.00

+120.42%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Altman Z 3.10 — safe zone

+ Debt/equity 0.19x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-70.10M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$1.86M	$0.00	$0.00	$0.00
Net income	$-89.06M	$-95.99M	$-152.15M	$-299.62M	$-91.10M
EPS	—	—	—	—	$-4.66
Free cash flow	$-67.66M	$-92.24M	$-135.65M	$-241.73M	$-70.10M
Profit margin	—	-5,155.21%	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VERA	$2.57B	27	4.3	3.0	5.0	8.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Vera Therapeutics Inc trades at $35.84. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 3.10, it sits in the safe zone.

Frequently asked questions

What is Vera Therapeutics Inc's stock price?

Vera Therapeutics Inc (VERA) trades at $35.84.

Is Vera Therapeutics Inc overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of Vera Therapeutics Inc (VERA)?

The analyst target price is $79.00, representing +120.4% upside from the current price of $35.84.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

3.10 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

veratx.com

Quick metrics

P/S ratio—

ROE-50.70%

Beta1.17

50D MA$40.54

200D MA$34.90

Shares out0.07B

Float0.05B

Short ratio—

Avg volume1.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

VERA vs LLY →VERA vs JNJ →VERA vs ABBV →Stock screener →